Upregulation of CD19 + CD24 hi CD38 hi regulatory B cells is associated with a reduced risk of acute lung injury in elderly pneumonia patients

Acute lung injury (ALI) is a common complication in elderly pneumonia patients who have a rapid progression, and is accompanied by a high mortality rate. Because the treatment options of ALI are limited to supportive care, identifying pneumonia patients who are at higher risk of ALI development is the emphasis of many studies. Here, we approach this problem from an immunological perspective by examining CD19 + CD24 hi CD38 hi B cells, an important participant in acute and chronic inflammation. We find that elderly pneumonia patients have elevated CD19 + CD24 hi CD38 hi B cell frequency compared to healthy individuals. This B cell population may express a higher level of IL-10, which has been was shown to suppress CD4 + T cell-mediated proinflammatory cytokine interferon gamma (IFNg) and tumor necrosis factor alpha (TNFa) production, through an IL-10-dependent mechanism. We also observe that the frequency of CD19 + CD24 hi CD38 hi B cell is positively correlated with the frequency of CD4 + CD25 + Foxp3 + Tregs in peripheral blood. Moreover, consistent with CD19 + CD24 hi CD38 hi B cell’s anti-inflammatory role, we find that pneumonia patients who later developed ALI have reduced level of CD19 + CD24 hi CD38 hi B cells. Together, our results demonstrated that CD19 + CD24 hi CD38 hi B cells in pneumonia patients possess regulatory function in vivo, and are associated with a reduced ALI risk.